Skip to main content
Figure 4 | BMC Medicine

Figure 4

From: Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials

Figure 4

Effects of PDE5i over placebo on marker of cardiac hypertrophy. A) NT-proBNP in main and B) subgroup analyses for LVH patients. Diamond indicates the overall summary estimate for the analysis (width of the diamond represents the 95% CI); boxes indicate the weight of individual studies in the pooled analysis. CI: confidence interval; LVH; left ventricular hypertrophy; N-proBNP: N-terminal-pro brain natriuretic peptide; PDE5i: phosphodiesterase type 5 inhibitors.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us